financetom
Business
financetom
/
Business
/
Real estate tech firm Offerpad Q3 revenue misses analyst expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Real estate tech firm Offerpad Q3 revenue misses analyst expectations
Nov 3, 2025 1:57 PM

Overview

* Offerpad Q3 2025 revenue of $132.7M missed analyst expectations

* Adjusted EBITDA for Q3 2025 missed analyst estimates

* Company improved operating expenses by 38% yr/yr, reflecting cost efficiencies

Outlook

* Offerpad expects Q4 2025 revenue between $100 mln and $125 mln

* Company anticipates selling 300 to 350 homes in Q4 2025

* Adjusted EBITDA for Q4 2025 expected to be similar to Q3 2025

Result Drivers

* ASSET-LIGHT SERVICES - Expansion of asset-light services like HomePro, Renovate, and Direct+ positions Offerpad for scalable, higher-margin growth

* COST EFFICIENCIES - Operating expenses improved by 38% yr/yr due to ongoing cost efficiencies and streamlined operations

* LIQUIDITY STRENGTHENING - Total liquidity exceeds $75M, supported by Q3 and ongoing capital raise activities

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $132.69 $173.01

Revenue mln mln (4

Analysts

)

Q3 Net -$11.60

Income mln

Q3 Miss -$4.60 -$2.97

Adjusted mln mln (4

EBITDA Analysts

)

Q3 Gross $9.30

Profit mln

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the real estate services peer group is "buy."

* Wall Street's median 12-month price target for Offerpad Solutions Inc ( OPAD ) is $1.15, about 103.5% below its October 31 closing price of $2.34

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merchants Bancorp Q3 net income falls 11% 
Merchants Bancorp Q3 net income falls 11% 
Oct 28, 2025
Overview * Merchants Bancorp Q3 net income falls 11% yr/yr, but rises 44% from Q2 2025 * Q3 diluted EPS of $0.97, down 17% yr/yr, up 62% from Q2 2025 * Company executed credit default swap on $557 mln healthcare loan pool Outlook * Company did not provide specific financial guidance for future quarters in press release Result Drivers *...
Natgas producer Expand Energy posts quarterly profit on higher output
Natgas producer Expand Energy posts quarterly profit on higher output
Oct 28, 2025
Oct 28 (Reuters) - U.S. natural gas producer Expand Energy ( EXE ) reported a profit for the third quarter on Tuesday, compared with a year-ago loss, driven by increased output and stronger commodity prices. Average U.S. natural gas prices during the quarter jumped more than 26% over the year earlier, driven by strong liquefied natural gas exports and growing...
Mondelez International Q3 Adjusted Earnings Decline, Revenue Rises
Mondelez International Q3 Adjusted Earnings Decline, Revenue Rises
Oct 28, 2025
04:14 PM EDT, 10/28/2025 (MT Newswires) -- Mondelez International ( MDLZ ) reported Q3 adjusted earnings late Tuesday of $0.73 per diluted share, down from $0.95 a year earlier. Analysts polled by FactSet expected $0.71. Net revenue for the quarter ended Sept. 30 was $9.74 billion, up from $9.20 billion a year earlier. Analysts surveyed by FactSet expected $9.69 billion....
Medical devices maker OrthoPediatrics' Q3 adjusted EBITDA misses estimates
Medical devices maker OrthoPediatrics' Q3 adjusted EBITDA misses estimates
Oct 28, 2025
Overview * OrthoPediatrics ( KIDS ) Q3 revenue grows 12% yr/yr to $61.2 mln, driven by Trauma & Deformity * Adjusted EBITDA for Q3 rises 56% yr/yr but misses analyst expectations * Company reports GAAP diluted loss per share of $0.50, non-GAAP loss of $0.24 Outlook * Company forecasts full-year 2025 revenue between $233.5 mln and $234.5 mln * Company...
Copyright 2023-2025 - www.financetom.com All Rights Reserved